Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Deferiprone noninferior to deferoxamine for iron overload in SCD, rare anemias
- Author:
- Sharon Worcester
An oral iron chelator granted accelerated approval for thalassemia is noninferior to deferoxamine for iron overload in patients with sickle cell...
News
Psoriasis: A look back over the past 50 years, and forward to next steps
- Author:
- Sharon Worcester
“The progress has been breathtaking – there’s no other way to describe it.”
News
Registry data reveal temporal relationship between psoriasis symptoms and PsA onset
- Author:
- Sharon Worcester
ATLANTA – Age at the onset of psoriasis was the main factor that determined PsA symptom synchronicity, according a study of data from the PsART...
News
Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapy
- Author:
- Sharon Worcester
Dasatinib-based two-step induction and intensive consolidation before alloHCT for Ph+ALL extends benefits of TKI...
News
Sevuparin failed for acute VOC in sickle cell, but may have preventive potential
- Author:
- Sharon Worcester
The novel nonanticoagulant heparinoid drug sevuparin may have value in the setting of prodromal vaso-occlusive crisis in patients with SCD.
News
Liver fibrosis scores predict CV event risk associated with NAFLD
- Author:
- Sharon Worcester
NAFLD is associated with a twofold increase in cardiovascular events, and liver fibrosis in NAFLD is associated with a fourfold increase.
News
UKALL14: Rituximab improves EFS in B-ALL, but four doses not enough
- Author:
- Sharon Worcester
Rituximab may improve EFS in B-ALL regardless of Philadelphia chromosome status and CD20-positive expression level.
Article
APPRENTICE registry: Wide variation exists in acute pancreatitis treatment, outcomes
- Author:
- Sharon Worcester
Despite recent major advances, some areas of the world lag behind the current evidence regarding the management of acute pancreatitis.
News
APPRENTICE registry: Wide variation exists in acute pancreatitis treatment, outcomes
- Author:
- Sharon Worcester
Despite recent major advances, some areas of the world lag behind the current evidence regarding the management of acute pancreatitis.
News
Chemo-free induction-consolidation protocol for Ph+ ALL improved survival
- Author:
- Sharon Worcester
ORLANDO – A front-line chemo-free induction-consolidation protocol for Ph+ ALL resulted in high survival and molecular response rates in the phase...
News
Cognitive problems after extremely preterm birth persist
- Author:
- Sharon Worcester
Findings among 19-year-olds born extremely premature suggest cognitive and neuropsychological problems persist into early adulthood.
News
Delayed hospital admission after hip fracture raises mortality risk
- Author:
- Sharon Worcester
Most studies focus on surgery timing among hospitalized patients and fail to consider preadmission waiting time.
News
Oral paclitaxel bests IV version for tumor response, neuropathy incidence in mBC
- Author:
- Sharon Worcester
SAN ANTONIO – An oral formulation of paclitaxel given with the P-glycoprotein pump inhibitor encequidar improved...
News
First report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBC
- Author:
- Sharon Worcester
SAN ANTONIO – Adding atezolizumab, an anti–programmed death-ligand 1 (PD-L1) monoclonal antibody, to neoadjuvant...
News
ASH releases guidelines on managing cardiopulmonary and kidney disease in SCD
- Author:
- Sharon Worcester
ORLANDO – ASH has released the first of five new sets of sickle cell disease guidelines, with the first focusing on screening and management of...